SEC Form 4/A · accession 0001179110-16-027062
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
James A Geraghty
Director
Period of report
Jun 13, 2016
Accepted (ET)
Jun 29, 2016 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F2,F3 | $1.44 | Jun 13, 2016 | A | 52,500 | A | — | Jun 13, 2026 | Common Stock | 52,500 | 52,500 | D |
Explanation of responses
- F1This amended form is being filed to correct a clerical error in the number of derivative securities reported in table II of the original filing. The number of derivative securities reported in the original filing was 52,000 while the actual number of options granted is 52,500.
- F2This option was automatically granted pursuant to the Company's director compensation program on the date of the Company's 2016 annual meeting of stockholders at an exercise price equal to the closing price of the Company's common stock on the date of the grant.
- F3The options vest with respect to one third of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vest in eight equal quarterly installments following the first anniversary of the the date of the grant, subject to continued service as a director, and are granted under our 2013 Stock Incentive Plan.